Charles Pyke
10Patents
7h-index
40Co-inventors
62Inventor score
Filing activity: Jun 17, 1993 → Nov 12, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7887805B2 | Recombinant anti-epidermal growth factor receptor antibody compositions | Chemistry; Metallurgy | 35 | Active |
| US5519120A | Urokinase-type plasminogen activator receptor antibodies | Physics | 14 | Expired |
| US5660982A | Laminin chains: diagnostic uses | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8414896B2 | Recombinant anti-epidermal growth factor receptor antibody compositions | Chemistry; Metallurgy | 11 | Active |
| US6248712A | Urokinase-type plasminogen activator receptor | Physics | 10 | Expired |
| US5891664A | Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR) | Physics | 10 | Expired |
| US6113897A | Antibodies and their use | Physics | 9 | Expired |
| US6224865A | Suppression of inhibitors | Physics | 3 | Expired |
| US6955924B2 | Laminin chains: diagnostic uses | Chemistry; Metallurgy | 1 | Expired |
| US6143505A | Laminin chains: diagnostic and therapeutic use | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.